

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | signal peptide processing (GO:0006465) | 8.95166425 |
| 2 | antigen processing and presentation of endogenous antigen (GO:0019883) | 8.67218864 |
| 3 | negative regulation of glucose import (GO:0046325) | 8.52271256 |
| 4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 8.31159877 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 8.31159877 |
| 6 | protein activation cascade (GO:0072376) | 7.92733407 |
| 7 | negative regulation of B cell proliferation (GO:0030889) | 7.57713693 |
| 8 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 7.18388569 |
| 9 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 7.18388569 |
| 10 | Fc-gamma receptor signaling pathway (GO:0038094) | 7.18388569 |
| 11 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 7.08468283 |
| 12 | positive regulation of respiratory burst (GO:0060267) | 6.93794886 |
| 13 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 6.72016716 |
| 14 | negative regulation of glucose transport (GO:0010829) | 6.71539761 |
| 15 | humoral immune response (GO:0006959) | 6.40776351 |
| 16 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.09698968 |
| 17 | glomerular filtration (GO:0003094) | 5.90621140 |
| 18 | retina homeostasis (GO:0001895) | 5.68635420 |
| 19 | regulation of B cell proliferation (GO:0030888) | 5.43274320 |
| 20 | gonadal mesoderm development (GO:0007506) | 5.34740066 |
| 21 | renal filtration (GO:0097205) | 5.27066058 |
| 22 | B cell receptor signaling pathway (GO:0050853) | 5.24566622 |
| 23 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 5.21047329 |
| 24 | apoptotic cell clearance (GO:0043277) | 5.19443791 |
| 25 | regulation of cellular extravasation (GO:0002691) | 5.08167811 |
| 26 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 4.96420423 |
| 27 | regulation of respiratory burst (GO:0060263) | 4.81404216 |
| 28 | angiotensin maturation (GO:0002003) | 4.73183017 |
| 29 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 4.64011916 |
| 30 | immunoglobulin mediated immune response (GO:0016064) | 4.61137726 |
| 31 | L-fucose catabolic process (GO:0042355) | 4.44501016 |
| 32 | fucose catabolic process (GO:0019317) | 4.44501016 |
| 33 | L-fucose metabolic process (GO:0042354) | 4.44501016 |
| 34 | positive regulation of immunoglobulin production (GO:0002639) | 4.43148209 |
| 35 | exocrine pancreas development (GO:0031017) | 4.35880289 |
| 36 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.34937417 |
| 37 | antimicrobial humoral response (GO:0019730) | 4.29544683 |
| 38 | antibacterial humoral response (GO:0019731) | 4.26881790 |
| 39 | positive regulation of B cell differentiation (GO:0045579) | 4.24151368 |
| 40 | intestinal absorption (GO:0050892) | 4.23412265 |
| 41 | regulation of guanylate cyclase activity (GO:0031282) | 4.21065303 |
| 42 | positive regulation of Rho protein signal transduction (GO:0035025) | 4.15613316 |
| 43 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 4.13068009 |
| 44 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 4.08844833 |
| 45 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 4.07105480 |
| 46 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.05705060 |
| 47 | negative regulation of B cell activation (GO:0050869) | 4.01940292 |
| 48 | regulation of antigen processing and presentation (GO:0002577) | 4.00273589 |
| 49 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.99972309 |
| 50 | regulation of B cell differentiation (GO:0045577) | 3.99332134 |
| 51 | transcytosis (GO:0045056) | 3.97145155 |
| 52 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.95583603 |
| 53 | peptidyl-asparagine modification (GO:0018196) | 3.90876967 |
| 54 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.87502925 |
| 55 | cellular response to antibiotic (GO:0071236) | 3.83145456 |
| 56 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.82846011 |
| 57 | cellular response to unfolded protein (GO:0034620) | 3.82378259 |
| 58 | positive regulation of Rap GTPase activity (GO:0032854) | 3.79268900 |
| 59 | positive regulation of nuclease activity (GO:0032075) | 3.77684936 |
| 60 | response to endoplasmic reticulum stress (GO:0034976) | 3.72749948 |
| 61 | sulfate transmembrane transport (GO:1902358) | 3.72740639 |
| 62 | positive regulation of antigen processing and presentation (GO:0002579) | 3.72670452 |
| 63 | regulation of B cell activation (GO:0050864) | 3.71118620 |
| 64 | regulation of nuclease activity (GO:0032069) | 3.66839408 |
| 65 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.65357761 |
| 66 | B cell proliferation (GO:0042100) | 3.64158596 |
| 67 | protein N-linked glycosylation (GO:0006487) | 3.63668279 |
| 68 | regulation of immunoglobulin production (GO:0002637) | 3.63464423 |
| 69 | mature B cell differentiation (GO:0002335) | 3.62545467 |
| 70 | Golgi transport vesicle coating (GO:0048200) | 3.62526089 |
| 71 | COPI coating of Golgi vesicle (GO:0048205) | 3.62526089 |
| 72 | cellular response to topologically incorrect protein (GO:0035967) | 3.56524055 |
| 73 | B cell mediated immunity (GO:0019724) | 3.52440696 |
| 74 | ER-nucleus signaling pathway (GO:0006984) | 3.49216358 |
| 75 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.48568746 |
| 76 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.48416632 |
| 77 | respiratory burst (GO:0045730) | 3.47298309 |
| 78 | regulation of B cell apoptotic process (GO:0002902) | 3.46881302 |
| 79 | positive thymic T cell selection (GO:0045059) | 3.46069116 |
| 80 | mature B cell differentiation involved in immune response (GO:0002313) | 3.43851536 |
| 81 | cellular response to zinc ion (GO:0071294) | 3.41710287 |
| 82 | production of molecular mediator of immune response (GO:0002440) | 3.38311587 |
| 83 | negative regulation of cellular response to insulin stimulus (GO:1900077) | 3.35924679 |
| 84 | immune response-activating signal transduction (GO:0002757) | 3.32425470 |
| 85 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 3.28944612 |
| 86 | cellular glucuronidation (GO:0052695) | 3.28333028 |
| 87 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.27786079 |
| 88 | labyrinthine layer development (GO:0060711) | 3.25648485 |
| 89 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.22687812 |
| 90 | oligosaccharide biosynthetic process (GO:0009312) | 3.22570476 |
| 91 | glucuronate metabolic process (GO:0019585) | 3.20123434 |
| 92 | uronic acid metabolic process (GO:0006063) | 3.20123434 |
| 93 | phenylpropanoid metabolic process (GO:0009698) | 3.17421719 |
| 94 | positive regulation of response to oxidative stress (GO:1902884) | 3.16178567 |
| 95 | positive regulation of cellular response to oxidative stress (GO:1900409) | 3.16178567 |
| 96 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 3.15518634 |
| 97 | regulation of regulatory T cell differentiation (GO:0045589) | 3.13802568 |
| 98 | regulation of vitamin metabolic process (GO:0030656) | 3.13685295 |
| 99 | cellular response to interferon-gamma (GO:0071346) | 3.12785778 |
| 100 | regulation of Rap GTPase activity (GO:0032317) | 3.12039420 |
| 101 | NADH metabolic process (GO:0006734) | 3.11066653 |
| 102 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.09980063 |
| 103 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.09978986 |
| 104 | intestinal epithelial cell development (GO:0060576) | 3.09597635 |
| 105 | proline biosynthetic process (GO:0006561) | 3.09516337 |
| 106 | defense response to Gram-negative bacterium (GO:0050829) | 3.08248370 |
| 107 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.07957487 |
| 108 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.07957487 |
| 109 | endocrine process (GO:0050886) | 3.07957487 |
| 110 | cytidine metabolic process (GO:0046087) | 3.07903139 |
| 111 | cytidine catabolic process (GO:0006216) | 3.07903139 |
| 112 | cytidine deamination (GO:0009972) | 3.07903139 |
| 113 | detection of bacterium (GO:0016045) | 3.07659401 |
| 114 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.06967833 |
| 115 | nerve growth factor signaling pathway (GO:0038180) | 3.05827870 |
| 116 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.05475101 |
| 117 | maternal placenta development (GO:0001893) | 3.03608544 |
| 118 | activation of immune response (GO:0002253) | 3.01949240 |
| 119 | sulfate transport (GO:0008272) | 3.01871359 |
| 120 | glycosphingolipid catabolic process (GO:0046479) | 2.98026296 |
| 121 | response to type I interferon (GO:0034340) | 2.97656164 |
| 122 | type I interferon signaling pathway (GO:0060337) | 2.94858875 |
| 123 | cellular response to type I interferon (GO:0071357) | 2.94858875 |
| 124 | immune response-regulating cell surface receptor signaling pathway (GO:0002768) | 2.93696738 |
| 125 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 2.93474561 |
| 126 | O-glycan processing (GO:0016266) | 2.92951207 |
| 127 | Fc-epsilon receptor signaling pathway (GO:0038095) | 2.92580239 |
| 128 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.91615176 |
| 129 | detection of other organism (GO:0098543) | 2.90390895 |
| 130 | response to unfolded protein (GO:0006986) | 2.87232774 |
| 131 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.86339528 |
| 132 | T cell costimulation (GO:0031295) | 2.86242022 |
| 133 | negative thymic T cell selection (GO:0045060) | 2.85901434 |
| 134 | positive regulation of production of molecular mediator of immune response (GO:0002702) | 2.84580110 |
| 135 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.84095705 |
| 136 | glycolipid catabolic process (GO:0019377) | 2.82392561 |
| 137 | positive regulation of pseudopodium assembly (GO:0031274) | 2.82384294 |
| 138 | lymphocyte costimulation (GO:0031294) | 2.81811856 |
| 139 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.81746051 |
| 140 | COPII vesicle coating (GO:0048208) | 2.81317948 |
| 141 | Fc receptor signaling pathway (GO:0038093) | 2.80523656 |
| 142 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.79862043 |
| 143 | natural killer cell mediated immunity (GO:0002228) | 2.79862043 |
| 144 | response to interferon-gamma (GO:0034341) | 2.79088355 |
| 145 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.77495658 |
| 146 | peptide catabolic process (GO:0043171) | 2.76346974 |
| 147 | regulation of cGMP biosynthetic process (GO:0030826) | 2.74222108 |
| 148 | regulation of interferon-alpha production (GO:0032647) | 2.74175152 |
| 149 | cell redox homeostasis (GO:0045454) | 2.74037104 |
| 150 | establishment of endothelial barrier (GO:0061028) | 2.73359385 |
| 151 | tongue development (GO:0043586) | 2.72462946 |
| 152 | ethanol oxidation (GO:0006069) | 2.72021487 |
| 153 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 2.71841954 |
| 154 | response to topologically incorrect protein (GO:0035966) | 2.69983241 |
| 155 | adhesion of symbiont to host cell (GO:0044650) | 2.67923026 |
| 156 | virion attachment to host cell (GO:0019062) | 2.67923026 |
| 157 | negative regulation of cell killing (GO:0031342) | 2.67224754 |
| 158 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.67224754 |
| 159 | renal system process involved in regulation of blood volume (GO:0001977) | 2.66247941 |
| 160 | dendritic cell chemotaxis (GO:0002407) | 2.66138557 |
| 161 | regulation of systemic arterial blood pressure (GO:0003073) | 2.64893036 |
| 162 | ceramide catabolic process (GO:0046514) | 2.63884280 |
| 163 | bile acid and bile salt transport (GO:0015721) | 2.62871578 |
| 164 | thrombin receptor signaling pathway (GO:0070493) | 2.62084141 |
| 165 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.59772954 |
| 166 | cellular response to reactive nitrogen species (GO:1902170) | 2.59391328 |
| 167 | eosinophil chemotaxis (GO:0048245) | 2.59348108 |
| 168 | positive T cell selection (GO:0043368) | 2.59163334 |
| 169 | NIK/NF-kappaB signaling (GO:0038061) | 2.56899031 |
| 170 | GDP-mannose metabolic process (GO:0019673) | 2.56838626 |
| 171 | defense response to protozoan (GO:0042832) | 2.53240253 |
| 172 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.51999237 |
| 173 | bicarbonate transport (GO:0015701) | 2.49179211 |
| 174 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.48328086 |
| 175 | regulation of pseudopodium assembly (GO:0031272) | 2.46822734 |
| 176 | positive regulation of type 2 immune response (GO:0002830) | 2.45290400 |
| 177 | response to nitric oxide (GO:0071731) | 2.44901479 |
| 178 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.44603983 |
| 179 | complement activation, classical pathway (GO:0006958) | 15.9131498 |
| 180 | complement activation (GO:0006956) | 12.1951840 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.67230512 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.79506366 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.13177844 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.60624833 |
| 5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.26829910 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.12100571 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.00494660 |
| 8 | MYC_22102868_ChIP-Seq_BL_Human | 3.67561862 |
| 9 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 3.39288577 |
| 10 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.38091797 |
| 11 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 3.34476616 |
| 12 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.98378232 |
| 13 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.92634942 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.91381035 |
| 15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.70024633 |
| 16 | MYB_26560356_Chip-Seq_TH2_Human | 2.59123157 |
| 17 | MAF_26560356_Chip-Seq_TH1_Human | 2.57478513 |
| 18 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.51626651 |
| 19 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.49635712 |
| 20 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.48809741 |
| 21 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.36383369 |
| 22 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.33761119 |
| 23 | MYB_26560356_Chip-Seq_TH1_Human | 2.32129727 |
| 24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.29581808 |
| 25 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.26887225 |
| 26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.26619729 |
| 27 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.24802513 |
| 28 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.21441693 |
| 29 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.09994961 |
| 30 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.09757281 |
| 31 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.99062807 |
| 32 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.95686489 |
| 33 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.93135641 |
| 34 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.89847463 |
| 35 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.84499050 |
| 36 | GATA1_22025678_ChIP-Seq_K562_Human | 1.84131394 |
| 37 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.81657766 |
| 38 | UTX_26944678_Chip-Seq_JUKART_Human | 1.79461469 |
| 39 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.75583633 |
| 40 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.74269500 |
| 41 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.73459183 |
| 42 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.69507180 |
| 43 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.67141710 |
| 44 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.66250463 |
| 45 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.65377547 |
| 46 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.63556860 |
| 47 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.62893018 |
| 48 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.62578855 |
| 49 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.58821435 |
| 50 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.56664256 |
| 51 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.55729576 |
| 52 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.51561500 |
| 53 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.51341251 |
| 54 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.50766027 |
| 55 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.47674504 |
| 56 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.46782481 |
| 57 | GATA3_26560356_Chip-Seq_TH2_Human | 1.45219381 |
| 58 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.43355988 |
| 59 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.42823884 |
| 60 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.42620692 |
| 61 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.40052498 |
| 62 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.36097667 |
| 63 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.33791965 |
| 64 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32146808 |
| 65 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31120400 |
| 66 | MAF_26560356_Chip-Seq_TH2_Human | 1.29626549 |
| 67 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26113680 |
| 68 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.24112090 |
| 69 | SPI1_23127762_ChIP-Seq_K562_Human | 1.22476317 |
| 70 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.17322106 |
| 71 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.14131782 |
| 72 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.13045067 |
| 73 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.12845062 |
| 74 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.12524406 |
| 75 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.12171808 |
| 76 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.11401835 |
| 77 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11042392 |
| 78 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.10889285 |
| 79 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09594819 |
| 80 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.08888418 |
| 81 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.08602746 |
| 82 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06765895 |
| 83 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.06313498 |
| 84 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.04748189 |
| 85 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.03565066 |
| 86 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02971339 |
| 87 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.02633995 |
| 88 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.01013135 |
| 89 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99574289 |
| 90 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.99555312 |
| 91 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.98044648 |
| 92 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97480341 |
| 93 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96742176 |
| 94 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96710567 |
| 95 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.96113764 |
| 96 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.96073668 |
| 97 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.95696008 |
| 98 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.95322115 |
| 99 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.95106334 |
| 100 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.95040737 |
| 101 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.94971530 |
| 102 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94846220 |
| 103 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.94733785 |
| 104 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.93939830 |
| 105 | GATA2_19941826_ChIP-Seq_K562_Human | 0.93134843 |
| 106 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.92787264 |
| 107 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.92030443 |
| 108 | RXR_22108803_ChIP-Seq_LS180_Human | 0.90442261 |
| 109 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90174033 |
| 110 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.89923963 |
| 111 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.89033243 |
| 112 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88945082 |
| 113 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88632569 |
| 114 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.87670151 |
| 115 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.87087789 |
| 116 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.86640665 |
| 117 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.86491484 |
| 118 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.85893907 |
| 119 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.85529221 |
| 120 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.85401154 |
| 121 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.83629262 |
| 122 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.83536032 |
| 123 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82993475 |
| 124 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.82283789 |
| 125 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.82258615 |
| 126 | P300_27268052_Chip-Seq_Bcells_Human | 0.81596101 |
| 127 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.81093771 |
| 128 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81008697 |
| 129 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.79866696 |
| 130 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.79510437 |
| 131 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.79234468 |
| 132 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.78070928 |
| 133 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.77685716 |
| 134 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.76688720 |
| 135 | GATA1_19941826_ChIP-Seq_K562_Human | 0.75889901 |
| 136 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.75777279 |
| 137 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.75735074 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.86639123 |
| 2 | MP0003303_peritoneal_inflammation | 4.81907343 |
| 3 | MP0001800_abnormal_humoral_immune | 4.24259184 |
| 4 | MP0001790_abnormal_immune_system | 3.93448320 |
| 5 | MP0005387_immune_system_phenotype | 3.93448320 |
| 6 | MP0005671_abnormal_response_to | 3.78427424 |
| 7 | MP0002138_abnormal_hepatobiliary_system | 3.56378045 |
| 8 | MP0004264_abnormal_extraembryonic_tissu | 3.51224120 |
| 9 | MP0003300_gastrointestinal_ulcer | 3.45925438 |
| 10 | MP0010234_abnormal_vibrissa_follicle | 3.44823232 |
| 11 | MP0002139_abnormal_hepatobiliary_system | 3.25658794 |
| 12 | MP0002452_abnormal_antigen_presenting | 3.22875769 |
| 13 | MP0002723_abnormal_immune_serum | 2.76080694 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.69473918 |
| 15 | MP0002420_abnormal_adaptive_immunity | 2.63179709 |
| 16 | MP0001819_abnormal_immune_cell | 2.59257311 |
| 17 | MP0001879_abnormal_lymphatic_vessel | 2.57232316 |
| 18 | MP0005025_abnormal_response_to | 2.47717606 |
| 19 | MP0001873_stomach_inflammation | 2.41019840 |
| 20 | MP0005085_abnormal_gallbladder_physiolo | 2.35232780 |
| 21 | MP0002398_abnormal_bone_marrow | 2.33724265 |
| 22 | MP0000716_abnormal_immune_system | 2.29323711 |
| 23 | MP0010155_abnormal_intestine_physiology | 2.27125923 |
| 24 | MP0004782_abnormal_surfactant_physiolog | 2.25870414 |
| 25 | MP0000685_abnormal_immune_system | 2.25706913 |
| 26 | MP0002148_abnormal_hypersensitivity_rea | 2.22191432 |
| 27 | MP0002166_altered_tumor_susceptibility | 2.17884364 |
| 28 | MP0000689_abnormal_spleen_morphology | 2.08721348 |
| 29 | MP0003763_abnormal_thymus_physiology | 2.07275772 |
| 30 | MP0009785_altered_susceptibility_to | 2.00628290 |
| 31 | MP0003436_decreased_susceptibility_to | 1.94486407 |
| 32 | MP0005310_abnormal_salivary_gland | 1.93763159 |
| 33 | MP0004043_abnormal_pH_regulation | 1.89523365 |
| 34 | MP0002429_abnormal_blood_cell | 1.89315201 |
| 35 | MP0001845_abnormal_inflammatory_respons | 1.87562709 |
| 36 | MP0002419_abnormal_innate_immunity | 1.84020904 |
| 37 | MP0006054_spinal_hemorrhage | 1.83856837 |
| 38 | MP0001853_heart_inflammation | 1.78664971 |
| 39 | MP0003866_abnormal_defecation | 1.75052917 |
| 40 | MP0002722_abnormal_immune_system | 1.74015573 |
| 41 | MP0005166_decreased_susceptibility_to | 1.70585732 |
| 42 | MP0001664_abnormal_digestion | 1.69482484 |
| 43 | MP0005365_abnormal_bile_salt | 1.69351849 |
| 44 | MP0000490_abnormal_crypts_of | 1.66857014 |
| 45 | MP0002933_joint_inflammation | 1.66507212 |
| 46 | MP0004947_skin_inflammation | 1.64820201 |
| 47 | MP0009333_abnormal_splenocyte_physiolog | 1.63453055 |
| 48 | MP0002006_tumorigenesis | 1.61615775 |
| 49 | MP0003868_abnormal_feces_composition | 1.53010370 |
| 50 | MP0001663_abnormal_digestive_system | 1.52768755 |
| 51 | MP0003252_abnormal_bile_duct | 1.45326860 |
| 52 | MP0002009_preneoplasia | 1.44351104 |
| 53 | MP0002405_respiratory_system_inflammati | 1.42628622 |
| 54 | MP0009379_abnormal_foot_pigmentation | 1.41674798 |
| 55 | MP0001765_abnormal_ion_homeostasis | 1.39960430 |
| 56 | MP0006082_CNS_inflammation | 1.39855891 |
| 57 | MP0004147_increased_porphyrin_level | 1.39175037 |
| 58 | MP0000465_gastrointestinal_hemorrhage | 1.23982866 |
| 59 | MP0000703_abnormal_thymus_morphology | 1.12540790 |
| 60 | MP0009840_abnormal_foam_cell | 1.09921801 |
| 61 | MP0005464_abnormal_platelet_physiology | 1.09451425 |
| 62 | MP0005381_digestive/alimentary_phenotyp | 1.07618421 |
| 63 | MP0002876_abnormal_thyroid_physiology | 1.07238944 |
| 64 | MP0003195_calcinosis | 1.05709475 |
| 65 | MP0008004_abnormal_stomach_pH | 1.04077616 |
| 66 | MP0003693_abnormal_embryo_hatching | 1.01957368 |
| 67 | MP0004510_myositis | 1.00859925 |
| 68 | MP0001533_abnormal_skeleton_physiology | 1.00759990 |
| 69 | MP0001666_abnormal_nutrient_absorption | 1.00355787 |
| 70 | MP0002136_abnormal_kidney_physiology | 0.99103439 |
| 71 | MP0003191_abnormal_cellular_cholesterol | 0.96623846 |
| 72 | MP0000477_abnormal_intestine_morphology | 0.96483415 |
| 73 | MP0001919_abnormal_reproductive_system | 0.95839263 |
| 74 | MP0008469_abnormal_protein_level | 0.94328762 |
| 75 | MP0002693_abnormal_pancreas_physiology | 0.93428841 |
| 76 | MP0003806_abnormal_nucleotide_metabolis | 0.92144340 |
| 77 | MP0001191_abnormal_skin_condition | 0.90427254 |
| 78 | MP0002019_abnormal_tumor_incidence | 0.90369025 |
| 79 | MP0004019_abnormal_vitamin_homeostasis | 0.90351070 |
| 80 | MP0000003_abnormal_adipose_tissue | 0.88900257 |
| 81 | MP0005360_urolithiasis | 0.85505282 |
| 82 | MP0001764_abnormal_homeostasis | 0.85058348 |
| 83 | MP0003075_altered_response_to | 0.84544350 |
| 84 | MP0005332_abnormal_amino_acid | 0.83108949 |
| 85 | MP0001545_abnormal_hematopoietic_system | 0.81535640 |
| 86 | MP0005397_hematopoietic_system_phenotyp | 0.81535640 |
| 87 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.80977636 |
| 88 | MP0003724_increased_susceptibility_to | 0.78246434 |
| 89 | MP0003045_fibrosis | 0.78129228 |
| 90 | MP0000609_abnormal_liver_physiology | 0.77376620 |
| 91 | MP0005076_abnormal_cell_differentiation | 0.76307276 |
| 92 | MP0005319_abnormal_enzyme/_coenzyme | 0.74597955 |
| 93 | MP0001756_abnormal_urination | 0.74561775 |
| 94 | MP0005023_abnormal_wound_healing | 0.74553027 |
| 95 | MP0003656_abnormal_erythrocyte_physiolo | 0.74457284 |
| 96 | MP0010352_gastrointestinal_tract_polyps | 0.74165222 |
| 97 | MP0004858_abnormal_nervous_system | 0.73970237 |
| 98 | MP0002396_abnormal_hematopoietic_system | 0.72984317 |
| 99 | MP0000613_abnormal_salivary_gland | 0.72534644 |
| 100 | MP0003943_abnormal_hepatobiliary_system | 0.72503053 |
| 101 | MP0000678_abnormal_parathyroid_gland | 0.69676845 |
| 102 | MP0000470_abnormal_stomach_morphology | 0.69162951 |
| 103 | MP0003183_abnormal_peptide_metabolism | 0.69126760 |
| 104 | MP0005451_abnormal_body_composition | 0.68455331 |
| 105 | MP0005058_abnormal_lysosome_morphology | 0.67740008 |
| 106 | MP0009643_abnormal_urine_homeostasis | 0.67594623 |
| 107 | MP0002796_impaired_skin_barrier | 0.67479374 |
| 108 | MP0005165_increased_susceptibility_to | 0.66827482 |
| 109 | MP0000604_amyloidosis | 0.66253952 |
| 110 | MP0002168_other_aberrant_phenotype | 0.65240163 |
| 111 | MP0009764_decreased_sensitivity_to | 0.64637839 |
| 112 | MP0001944_abnormal_pancreas_morphology | 0.63911842 |
| 113 | MP0004808_abnormal_hematopoietic_stem | 0.63870255 |
| 114 | MP0000858_altered_metastatic_potential | 0.61841445 |
| 115 | MP0010329_abnormal_lipoprotein_level | 0.61180293 |
| 116 | MP0010307_abnormal_tumor_latency | 0.60759951 |
| 117 | MP0000013_abnormal_adipose_tissue | 0.60320951 |
| 118 | MP0008872_abnormal_physiological_respon | 0.59447030 |
| 119 | MP0002998_abnormal_bone_remodeling | 0.57971085 |
| 120 | MP0002133_abnormal_respiratory_system | 0.57148934 |
| 121 | MP0005388_respiratory_system_phenotype | 0.57148934 |
| 122 | MP0003795_abnormal_bone_structure | 0.54249903 |
| 123 | MP0009931_abnormal_skin_appearance | 0.51319586 |
| 124 | MP0002083_premature_death | 0.49049480 |
| 125 | MP0001881_abnormal_mammary_gland | 0.48721736 |
| 126 | MP0005636_abnormal_mineral_homeostasis | 0.47849360 |
| 127 | MP0003566_abnormal_cell_adhesion | 0.47717342 |
| 128 | MP0001542_abnormal_bone_strength | 0.46870859 |
| 129 | MP0003828_pulmonary_edema | 0.46340455 |
| 130 | MP0009763_increased_sensitivity_to | 0.46241946 |
| 131 | MP0000249_abnormal_blood_vessel | 0.45760239 |
| 132 | MP0003448_altered_tumor_morphology | 0.45120318 |
| 133 | MP0000681_abnormal_thyroid_gland | 0.45046587 |
| 134 | MP0009765_abnormal_xenobiotic_induced | 0.43403643 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 9.03619279 |
| 2 | Abnormality of B cell number (HP:0010975) | 8.46959273 |
| 3 | B lymphocytopenia (HP:0010976) | 8.46959273 |
| 4 | Colitis (HP:0002583) | 7.30014211 |
| 5 | Recurrent sinusitis (HP:0011108) | 6.65169948 |
| 6 | Recurrent bronchitis (HP:0002837) | 6.55923589 |
| 7 | Hyperactive renin-angiotensin system (HP:0000841) | 6.42584478 |
| 8 | Cellulitis (HP:0100658) | 6.06031236 |
| 9 | Inflammation of the large intestine (HP:0002037) | 5.67649626 |
| 10 | Papilloma (HP:0012740) | 5.40025564 |
| 11 | Verrucae (HP:0200043) | 5.40025564 |
| 12 | Gastrointestinal inflammation (HP:0004386) | 5.35899494 |
| 13 | Decreased circulating renin level (HP:0003351) | 5.32611584 |
| 14 | Recurrent viral infections (HP:0004429) | 5.28267557 |
| 15 | IgM deficiency (HP:0002850) | 5.26067276 |
| 16 | Meningitis (HP:0001287) | 5.07311609 |
| 17 | Gastrointestinal stroma tumor (HP:0100723) | 5.07212143 |
| 18 | Recurrent pneumonia (HP:0006532) | 4.95845214 |
| 19 | Chronic otitis media (HP:0000389) | 4.64748937 |
| 20 | Metabolic alkalosis (HP:0200114) | 4.47882916 |
| 21 | Abnormality of renin-angiotensin system (HP:0000847) | 4.40464077 |
| 22 | Chronic sinusitis (HP:0011109) | 4.29221196 |
| 23 | Onycholysis (HP:0001806) | 4.17607037 |
| 24 | Recurrent lower respiratory tract infections (HP:0002783) | 4.09257183 |
| 25 | Interstitial pulmonary disease (HP:0006530) | 4.00358539 |
| 26 | Systemic lupus erythematosus (HP:0002725) | 3.97038044 |
| 27 | Myositis (HP:0100614) | 3.96981695 |
| 28 | Chronic diarrhea (HP:0002028) | 3.94714223 |
| 29 | Osteomyelitis (HP:0002754) | 3.93034344 |
| 30 | Bronchitis (HP:0012387) | 3.92079251 |
| 31 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.91946856 |
| 32 | Malnutrition (HP:0004395) | 3.79628920 |
| 33 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.77090272 |
| 34 | Alkalosis (HP:0001948) | 3.68805356 |
| 35 | Flat acetabular roof (HP:0003180) | 3.65171693 |
| 36 | Skin rash (HP:0000988) | 3.63192603 |
| 37 | Recurrent otitis media (HP:0000403) | 3.47271230 |
| 38 | Abnormality of chloride homeostasis (HP:0011422) | 3.45100128 |
| 39 | Emphysema (HP:0002097) | 3.43961910 |
| 40 | Vasculitis (HP:0002633) | 3.32083670 |
| 41 | Abnormality of small intestinal villus morphology (HP:0011472) | 3.27128093 |
| 42 | Villous atrophy (HP:0011473) | 3.27128093 |
| 43 | Hyperaldosteronism (HP:0000859) | 3.23143132 |
| 44 | IgA deficiency (HP:0002720) | 3.22816678 |
| 45 | Abnormality of T cell physiology (HP:0011840) | 3.18108257 |
| 46 | Optic neuritis (HP:0100653) | 3.15755348 |
| 47 | Retrobulbar optic neuritis (HP:0100654) | 3.15755348 |
| 48 | Sepsis (HP:0100806) | 3.13896082 |
| 49 | Dry hair (HP:0011359) | 3.01011385 |
| 50 | Nasal polyposis (HP:0100582) | 2.97444811 |
| 51 | Erythema (HP:0010783) | 2.92063865 |
| 52 | Restrictive lung disease (HP:0002091) | 2.89206010 |
| 53 | Pulmonary infiltrates (HP:0002113) | 2.88250171 |
| 54 | Basal cell carcinoma (HP:0002671) | 2.84630637 |
| 55 | Ileus (HP:0002595) | 2.84248455 |
| 56 | Conical tooth (HP:0000698) | 2.81091617 |
| 57 | Orchitis (HP:0100796) | 2.79041815 |
| 58 | Spontaneous hematomas (HP:0007420) | 2.75572889 |
| 59 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.73251100 |
| 60 | Recurrent abscess formation (HP:0002722) | 2.73119751 |
| 61 | IgG deficiency (HP:0004315) | 2.72233632 |
| 62 | Eczematoid dermatitis (HP:0000976) | 2.70661474 |
| 63 | Urticaria (HP:0001025) | 2.65434745 |
| 64 | Abnormality of the nasal mucosa (HP:0000433) | 2.64325516 |
| 65 | Bronchiectasis (HP:0002110) | 2.63804392 |
| 66 | Lymphopenia (HP:0001888) | 2.63141375 |
| 67 | Abnormality of the prostate (HP:0008775) | 2.54977597 |
| 68 | Autoimmune hemolytic anemia (HP:0001890) | 2.54020926 |
| 69 | Abdominal distention (HP:0003270) | 2.53230536 |
| 70 | Abnormality of T cells (HP:0002843) | 2.52373428 |
| 71 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.50900407 |
| 72 | Thyroiditis (HP:0100646) | 2.50435438 |
| 73 | Recurrent fungal infections (HP:0002841) | 2.42661809 |
| 74 | Nephritis (HP:0000123) | 2.40715983 |
| 75 | Abnormality of proline metabolism (HP:0010907) | 2.39862494 |
| 76 | Hydroxyprolinuria (HP:0003080) | 2.39862494 |
| 77 | Keratoconjunctivitis sicca (HP:0001097) | 2.39536052 |
| 78 | Abnormality of complement system (HP:0005339) | 2.37665662 |
| 79 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.37315191 |
| 80 | Premature loss of primary teeth (HP:0006323) | 2.35233531 |
| 81 | Pustule (HP:0200039) | 2.35050101 |
| 82 | Prostate neoplasm (HP:0100787) | 2.34534045 |
| 83 | Obstructive lung disease (HP:0006536) | 2.34389554 |
| 84 | Chronic obstructive pulmonary disease (HP:0006510) | 2.34389554 |
| 85 | Recurrent bacterial skin infections (HP:0005406) | 2.32903347 |
| 86 | Glomerulonephritis (HP:0000099) | 2.32119283 |
| 87 | Vacuolated lymphocytes (HP:0001922) | 2.31325775 |
| 88 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.30666342 |
| 89 | Hyponatremia (HP:0002902) | 2.29950622 |
| 90 | Skin ulcer (HP:0200042) | 2.29915975 |
| 91 | Squamous cell carcinoma (HP:0002860) | 2.29663271 |
| 92 | Panhypogammaglobulinemia (HP:0003139) | 2.29543841 |
| 93 | Hypokalemia (HP:0002900) | 2.29370744 |
| 94 | Thrombocytosis (HP:0001894) | 2.28551926 |
| 95 | Fat malabsorption (HP:0002630) | 2.28321942 |
| 96 | Ridged nail (HP:0001807) | 2.27233884 |
| 97 | Abnormal tarsal ossification (HP:0008369) | 2.26949020 |
| 98 | Hyperkalemia (HP:0002153) | 2.23626733 |
| 99 | Keratoconjunctivitis (HP:0001096) | 2.21303651 |
| 100 | Complement deficiency (HP:0004431) | 2.21209242 |
| 101 | Neutropenia (HP:0001875) | 2.20437310 |
| 102 | Autoimmune thrombocytopenia (HP:0001973) | 2.17512869 |
| 103 | Right ventricular cardiomyopathy (HP:0011663) | 2.17166263 |
| 104 | Amelogenesis imperfecta (HP:0000705) | 2.15526266 |
| 105 | Gastrointestinal infarctions (HP:0005244) | 2.14674373 |
| 106 | Abnormality of vitamin B metabolism (HP:0004340) | 2.14075371 |
| 107 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.12805021 |
| 108 | Hemorrhage of the eye (HP:0011885) | 2.11761865 |
| 109 | Abnormality of incisor morphology (HP:0011063) | 2.11705705 |
| 110 | Flattened epiphyses (HP:0003071) | 2.11480620 |
| 111 | Abnormality of macrophages (HP:0004311) | 2.10631338 |
| 112 | Conjugated hyperbilirubinemia (HP:0002908) | 2.10486872 |
| 113 | Increased IgE level (HP:0003212) | 2.09778309 |
| 114 | Abnormality of potassium homeostasis (HP:0011042) | 2.07736885 |
| 115 | Flat capital femoral epiphysis (HP:0003370) | 2.07292357 |
| 116 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.04292495 |
| 117 | Dehydration (HP:0001944) | 2.02537289 |
| 118 | Mediastinal lymphadenopathy (HP:0100721) | 1.99882175 |
| 119 | Congenital, generalized hypertrichosis (HP:0004540) | 1.96154554 |
| 120 | Hypergammaglobulinemia (HP:0010702) | 1.95416282 |
| 121 | Recurrent skin infections (HP:0001581) | 1.94356159 |
| 122 | Adrenal overactivity (HP:0002717) | 1.93909678 |
| 123 | Neonatal short-limb short stature (HP:0008921) | 1.93903867 |
| 124 | Hemoptysis (HP:0002105) | 1.93458960 |
| 125 | Encephalitis (HP:0002383) | 1.93366172 |
| 126 | Gingivitis (HP:0000230) | 1.93294791 |
| 127 | Arterial thrombosis (HP:0004420) | 1.93009552 |
| 128 | Pulmonary embolism (HP:0002204) | 1.90141657 |
| 129 | Abnormality of T cell number (HP:0011839) | 1.89966442 |
| 130 | Petechiae (HP:0000967) | 1.86577239 |
| 131 | Teleangiectasia of the skin (HP:0100585) | 1.86246123 |
| 132 | Arthralgia (HP:0002829) | 1.85515534 |
| 133 | T lymphocytopenia (HP:0005403) | 1.83128044 |
| 134 | Myocardial infarction (HP:0001658) | 1.79778701 |
| 135 | Leukopenia (HP:0001882) | 1.77967067 |
| 136 | Vascular calcification (HP:0004934) | 1.74370958 |
| 137 | Blepharitis (HP:0000498) | 1.72715374 |
| 138 | Gangrene (HP:0100758) | 1.67831050 |
| 139 | Mitral stenosis (HP:0001718) | 1.61741470 |
| 140 | Recurrent cutaneous fungal infections (HP:0011370) | 1.61390862 |
| 141 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.61390862 |
| 142 | Lymphoma (HP:0002665) | 1.61271160 |
| 143 | Microcytic anemia (HP:0001935) | 1.60865737 |
| 144 | Fatigue (HP:0012378) | 1.57324206 |
| 145 | Cardiovascular calcification (HP:0011915) | 1.56547734 |
| 146 | Viral hepatitis (HP:0006562) | 1.56173190 |
| 147 | Chest pain (HP:0100749) | 1.53928902 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 6.69983117 |
| 2 | ACVR1B | 4.65408453 |
| 3 | MAP4K1 | 4.56056883 |
| 4 | NME2 | 4.31532676 |
| 5 | TBK1 | 3.00499007 |
| 6 | MAP3K14 | 2.93471450 |
| 7 | MST1R | 2.87176675 |
| 8 | TYK2 | 2.82045973 |
| 9 | TXK | 2.80799514 |
| 10 | MAP3K13 | 2.70076348 |
| 11 | GRK6 | 2.55462540 |
| 12 | IKBKE | 2.42590281 |
| 13 | TAOK3 | 2.39174171 |
| 14 | IRAK3 | 2.34349378 |
| 15 | CSF1R | 2.27988656 |
| 16 | SYK | 2.27848868 |
| 17 | PIK3CA | 2.25094895 |
| 18 | STK39 | 2.18412115 |
| 19 | BMPR1B | 2.07232543 |
| 20 | MET | 2.04348423 |
| 21 | KIT | 1.96558957 |
| 22 | IRAK4 | 1.92391518 |
| 23 | RIPK4 | 1.86119876 |
| 24 | EPHA2 | 1.84293766 |
| 25 | OXSR1 | 1.78120154 |
| 26 | STK24 | 1.72132649 |
| 27 | JAK3 | 1.57631154 |
| 28 | FRK | 1.51357233 |
| 29 | EIF2AK3 | 1.45362511 |
| 30 | RIPK1 | 1.45224120 |
| 31 | BTK | 1.43997293 |
| 32 | JAK1 | 1.43394977 |
| 33 | BLK | 1.39857973 |
| 34 | IKBKB | 1.38628660 |
| 35 | MAP3K9 | 1.35840752 |
| 36 | LMTK2 | 1.35203254 |
| 37 | LYN | 1.29708843 |
| 38 | BCKDK | 1.28998875 |
| 39 | ITK | 1.28018956 |
| 40 | ARAF | 1.21984118 |
| 41 | TGFBR1 | 1.19796849 |
| 42 | BMPR2 | 1.18339532 |
| 43 | MAP3K10 | 1.17356148 |
| 44 | TEC | 1.13491594 |
| 45 | TGFBR2 | 1.13287270 |
| 46 | MST4 | 1.10024444 |
| 47 | MATK | 1.06475063 |
| 48 | HCK | 1.05669119 |
| 49 | PKN2 | 1.05412693 |
| 50 | SMG1 | 1.03174930 |
| 51 | PRKCH | 1.00686316 |
| 52 | SCYL2 | 0.99654756 |
| 53 | EPHA3 | 0.99283705 |
| 54 | LCK | 0.99172668 |
| 55 | HIPK2 | 0.94686494 |
| 56 | PIK3CG | 0.92784822 |
| 57 | MAP3K1 | 0.92565534 |
| 58 | CDK8 | 0.92355135 |
| 59 | KSR2 | 0.91288265 |
| 60 | FGFR3 | 0.91215343 |
| 61 | FGFR4 | 0.90965972 |
| 62 | NEK9 | 0.90801620 |
| 63 | STK10 | 0.90711970 |
| 64 | LRRK2 | 0.85875969 |
| 65 | ZAP70 | 0.83853931 |
| 66 | CSK | 0.83110282 |
| 67 | PRKCQ | 0.80465342 |
| 68 | TLK1 | 0.79962387 |
| 69 | CHUK | 0.78913282 |
| 70 | FES | 0.77919875 |
| 71 | EPHB1 | 0.76982326 |
| 72 | CDC42BPA | 0.76694725 |
| 73 | PRKG2 | 0.76201544 |
| 74 | SIK2 | 0.75515172 |
| 75 | EEF2K | 0.69871699 |
| 76 | PIM1 | 0.69027248 |
| 77 | WNK4 | 0.68739537 |
| 78 | PDPK1 | 0.66575476 |
| 79 | GRK1 | 0.65847708 |
| 80 | CAMKK2 | 0.60452003 |
| 81 | JAK2 | 0.59165610 |
| 82 | RAF1 | 0.57496610 |
| 83 | MAP2K3 | 0.57118921 |
| 84 | MAP3K2 | 0.56597597 |
| 85 | FLT3 | 0.55639159 |
| 86 | MAPK12 | 0.54298360 |
| 87 | PDK1 | 0.54109712 |
| 88 | MAP3K12 | 0.53843853 |
| 89 | RPS6KB2 | 0.53476907 |
| 90 | CDK19 | 0.51138722 |
| 91 | MAP2K2 | 0.49560826 |
| 92 | PRPF4B | 0.49136617 |
| 93 | FER | 0.48017978 |
| 94 | STK16 | 0.47250994 |
| 95 | CDK6 | 0.45702541 |
| 96 | FYN | 0.45370078 |
| 97 | NEK2 | 0.45100945 |
| 98 | PRKCI | 0.44064516 |
| 99 | RPS6KA4 | 0.42300138 |
| 100 | SIK1 | 0.42220202 |
| 101 | MAPK11 | 0.41956829 |
| 102 | PRKAA2 | 0.40589615 |
| 103 | MYLK | 0.40406138 |
| 104 | CLK1 | 0.37733113 |
| 105 | CAMKK1 | 0.37570117 |
| 106 | MAP3K7 | 0.35937993 |
| 107 | DDR2 | 0.35001262 |
| 108 | CDK9 | 0.34996844 |
| 109 | ABL1 | 0.34701529 |
| 110 | IRAK2 | 0.33689594 |
| 111 | TTN | 0.33484727 |
| 112 | PRKCD | 0.32031676 |
| 113 | EIF2AK1 | 0.31551953 |
| 114 | YES1 | 0.31412707 |
| 115 | MAPKAPK5 | 0.30215761 |
| 116 | TESK2 | 0.28569338 |
| 117 | RET | 0.28264808 |
| 118 | PDK2 | 0.27807666 |
| 119 | MOS | 0.27420423 |
| 120 | INSR | 0.25730886 |
| 121 | MAPK4 | 0.25214891 |
| 122 | NLK | 0.24932420 |
| 123 | MAPK7 | 0.24303941 |
| 124 | MAP3K8 | 0.23211566 |
| 125 | TNIK | 0.23063816 |
| 126 | ALK | 0.22661326 |
| 127 | EGFR | 0.21733110 |
| 128 | MAPKAPK2 | 0.20974278 |
| 129 | PRKD1 | 0.20511176 |
| 130 | IRAK1 | 0.20369143 |
| 131 | PTK6 | 0.18904583 |
| 132 | SIK3 | 0.17720682 |
| 133 | IGF1R | 0.16639964 |
| 134 | PRKD2 | 0.15022699 |
| 135 | MAP2K6 | 0.14514497 |
| 136 | CCNB1 | 0.14287056 |
| 137 | MAPK3 | 0.12852961 |
| 138 | MAPKAPK3 | 0.11901764 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 7.49880442 |
| 2 | Protein export_Homo sapiens_hsa03060 | 5.57590995 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.70009499 |
| 4 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 3.70536550 |
| 5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 3.41202884 |
| 6 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.07048888 |
| 7 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.06829026 |
| 8 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.88633071 |
| 9 | Asthma_Homo sapiens_hsa05310 | 2.86762008 |
| 10 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.35938348 |
| 11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.21079377 |
| 12 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.20899040 |
| 13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.17824635 |
| 14 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.12952000 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 2.09692742 |
| 16 | Allograft rejection_Homo sapiens_hsa05330 | 2.00325820 |
| 17 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.83420538 |
| 18 | Mineral absorption_Homo sapiens_hsa04978 | 1.58823187 |
| 19 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.55348585 |
| 20 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.51262862 |
| 21 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.49363051 |
| 22 | Other glycan degradation_Homo sapiens_hsa00511 | 1.39636123 |
| 23 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.34945487 |
| 24 | Malaria_Homo sapiens_hsa05144 | 1.34818190 |
| 25 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.33002313 |
| 26 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.32860004 |
| 27 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.31553819 |
| 28 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.29519339 |
| 29 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.19647869 |
| 30 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.19436722 |
| 31 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.13620225 |
| 32 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.13009739 |
| 33 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.12761539 |
| 34 | Measles_Homo sapiens_hsa05162 | 1.11004474 |
| 35 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.09821086 |
| 36 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.09194249 |
| 37 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.06001227 |
| 38 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.02182559 |
| 39 | Pertussis_Homo sapiens_hsa05133 | 1.01934246 |
| 40 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.99825077 |
| 41 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.98671190 |
| 42 | Tuberculosis_Homo sapiens_hsa05152 | 0.97030922 |
| 43 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.96490988 |
| 44 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.95948874 |
| 45 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.93392834 |
| 46 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.93195268 |
| 47 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.92626168 |
| 48 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.91037055 |
| 49 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.89098442 |
| 50 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.86985995 |
| 51 | Legionellosis_Homo sapiens_hsa05134 | 0.86004431 |
| 52 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.81406336 |
| 53 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.80973120 |
| 54 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.78853834 |
| 55 | Hepatitis B_Homo sapiens_hsa05161 | 0.78067390 |
| 56 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.77312200 |
| 57 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.75795394 |
| 58 | Phagosome_Homo sapiens_hsa04145 | 0.75779071 |
| 59 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.74913536 |
| 60 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.74559607 |
| 61 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.73120408 |
| 62 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.73112483 |
| 63 | Retinol metabolism_Homo sapiens_hsa00830 | 0.72862397 |
| 64 | Viral myocarditis_Homo sapiens_hsa05416 | 0.72379248 |
| 65 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.67502702 |
| 66 | Influenza A_Homo sapiens_hsa05164 | 0.66870945 |
| 67 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.66333467 |
| 68 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.66210131 |
| 69 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.64759952 |
| 70 | Apoptosis_Homo sapiens_hsa04210 | 0.64403336 |
| 71 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.63906379 |
| 72 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.63171671 |
| 73 | Bile secretion_Homo sapiens_hsa04976 | 0.61967146 |
| 74 | Base excision repair_Homo sapiens_hsa03410 | 0.60408167 |
| 75 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.58467496 |
| 76 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.58230461 |
| 77 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.56522023 |
| 78 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.56291959 |
| 79 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.56001194 |
| 80 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.53124273 |
| 81 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.52263423 |
| 82 | Hepatitis C_Homo sapiens_hsa05160 | 0.50448175 |
| 83 | Platelet activation_Homo sapiens_hsa04611 | 0.47837812 |
| 84 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.47761442 |
| 85 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.47063969 |
| 86 | HTLV-I infection_Homo sapiens_hsa05166 | 0.47034772 |
| 87 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.45777715 |
| 88 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.42985552 |
| 89 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.41695648 |
| 90 | Shigellosis_Homo sapiens_hsa05131 | 0.40660870 |
| 91 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.40590539 |
| 92 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.39187037 |
| 93 | Histidine metabolism_Homo sapiens_hsa00340 | 0.38556408 |
| 94 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.37360323 |
| 95 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.35754710 |
| 96 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.35460966 |
| 97 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.35320865 |
| 98 | Long-term potentiation_Homo sapiens_hsa04720 | 0.34625993 |
| 99 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.33710721 |
| 100 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.31789714 |
| 101 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.30217857 |
| 102 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.28360956 |
| 103 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.27844668 |
| 104 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.27559471 |
| 105 | Lysosome_Homo sapiens_hsa04142 | 0.27556464 |
| 106 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.26596842 |
| 107 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.25572954 |
| 108 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.25239770 |
| 109 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.25178687 |
| 110 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.20920878 |
| 111 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20290547 |
| 112 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.19592134 |
| 113 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.19318082 |
| 114 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.18568924 |
| 115 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.18548586 |
| 116 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.16337106 |
| 117 | Renin secretion_Homo sapiens_hsa04924 | 0.15707182 |
| 118 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.14618535 |
| 119 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.14530946 |
| 120 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.14456797 |
| 121 | DNA replication_Homo sapiens_hsa03030 | 0.14377824 |
| 122 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.14086566 |
| 123 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.13634286 |
| 124 | Insulin resistance_Homo sapiens_hsa04931 | 0.13307471 |
| 125 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.12491725 |
| 126 | Ribosome_Homo sapiens_hsa03010 | 0.11798543 |
| 127 | Prostate cancer_Homo sapiens_hsa05215 | 0.09631608 |
| 128 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.08973001 |
| 129 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.08331723 |
| 130 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.08272716 |
| 131 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.08125379 |
| 132 | ABC transporters_Homo sapiens_hsa02010 | 0.07884768 |
| 133 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.07671191 |
| 134 | Galactose metabolism_Homo sapiens_hsa00052 | 0.07291654 |
| 135 | Sulfur relay system_Homo sapiens_hsa04122 | 0.06817835 |

